Related Experiment Video
Updated: Aug 15, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
New acyclonucleosides: synthesis and anti-HIV activity
Amel Hadj-Bouazza1, Rachida Zerrouki, Pierre Krausz
1Laboratoire de Chimie des Substances Naturelles, Faculté des Sciences et Techniques, Université de Limoges, Limoges, France.
Researchers synthesized novel acyclic nucleosides using diverse chemical methods. These compounds were then tested for antiviral activity against human immunodeficiency virus type 1 (HIV-1).
Area of Science:
- Organic Chemistry
- Medicinal Chemistry
- Virology
Background:
- Acyclic nucleosides are important structural motifs in medicinal chemistry.
- Development of novel antiviral agents remains a critical area of research, particularly for human immunodeficiency virus type 1 (HIV-1).
Purpose of the Study:
- To synthesize a new series of acyclic nucleoside analogs.
- To evaluate the antiviral potential of these novel compounds against HIV-1.
Main Methods:
- Synthesis involved key reactions such as glycosylation, deprotection, oxidation/reduction, and halogenation/azidation of hydroxyl groups.
- Characterization of synthesized compounds utilized Nuclear Magnetic Resonance (NMR), mass spectrometry, and Infrared (IR) spectroscopy.
- Antiviral activity was assessed using HIV-1 infected cell lines.
Main Results:
- A library of novel acyclic nucleosides was successfully synthesized and characterized.
- Preliminary evaluation of antiviral properties against HIV-1 was performed.
Conclusions:
- The study established synthetic routes to novel acyclic nucleosides.
- The synthesized compounds represent potential candidates for further investigation as anti-HIV-1 agents.
Related Concept Videos
Antiviral Nucleoside Inhibitors
Inhibitors of Virion Maturation and Assembly
DNA Base Pairing
Inhibitors of Viral Protein Synthesis
Inhibitors Of Virion Release

